GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » D&D Pharmatech Inc (XKRX:347850) » Definitions » Sale Of Investment

D&D Pharmatech (XKRX:347850) Sale Of Investment : ₩0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is D&D Pharmatech Sale Of Investment?

D&D Pharmatech's sale of investment for the three months ended in Dec. 2024 was ₩0 Mil. It means D&D Pharmatech gained ₩0 Mil from selling investments. D&D Pharmatech's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was ₩0 Mil.

Compared with last quarter (₩0 Mil in Sep. 2024 ), D&D Pharmatech gained the same money from selling investments in Dec. 2024 (₩0 Mil).


D&D Pharmatech Sale Of Investment Historical Data

The historical data trend for D&D Pharmatech's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

D&D Pharmatech Sale Of Investment Chart

D&D Pharmatech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial - - - - -

D&D Pharmatech Quarterly Data
Dec18 Dec19 Dec20 Dec21 Dec22 Jun23 Sep23 Dec23 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

D&D Pharmatech Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


D&D Pharmatech Sale Of Investment Related Terms

Thank you for viewing the detailed overview of D&D Pharmatech's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


D&D Pharmatech Business Description

Traded in Other Exchanges
N/A
Address
4th floor, 24, Pangyo-ro 255beon-gil, Bundang-gu, Gyeonggi-do, Sampyeong-dong, I&C Building, Seongnam-si, KOR
D&D Pharmatech Inc is a company that comprises of experts in the field of bio-new drug research and development and technology commercialization, including basic scientists in the pharmaceutical biofield, manufacturing quality control (CMC) experts, and clinical development and technology transfer experts. Other business areas include the development of positron emission tomography (PET) imaging biomarkers conducted by Precision Molecular Inc. a 100% subsidiary, and single-cell sequencing related to degenerative brain diseases conducted by Valted Seq, Inc. The company utilizes drug delivery technologies such as PEGylation technology, which helps extend the administration interval using PEG and various chemicals, and platform technology that converts injectable drugs into oral preparations.

D&D Pharmatech Headlines

No Headlines